Christopher Hardy
About Christopher Hardy
Christopher Hardy serves as the Director of PV Systems and Analytics at Day One Biopharmaceuticals, a position he has held since 2023. He has extensive experience in pharmacovigilance and analytics, having worked in various roles at notable pharmaceutical companies.
Current Role at Day One Biopharmaceuticals
Christopher Hardy serves as the Director of PV Systems and Analytics at Day One Biopharmaceuticals. He has held this position since 2023, contributing to the company's pharmacovigilance efforts. His role involves overseeing the systems and analytics related to patient safety, ensuring compliance with regulatory standards. The position is remote, allowing for flexibility in his work environment.
Previous Experience in Pharmaceutical Industry
Before joining Day One Biopharmaceuticals, Christopher Hardy accumulated extensive experience in the pharmaceutical sector. He worked at Aimmune Therapeutics as Associate Director of PV Systems and Analytics from 2020 to 2023. Prior to that, he was with Alnylam Pharmaceuticals as Associate Director of Analytics from 2017 to 2020. His earlier roles include Senior Manager of Safety Systems at Vertex Pharmaceuticals from 2012 to 2016 and Reporting Manager at Sanofi Genzyme from 2010 to 2012.
Education at University of Massachusetts Amherst
Christopher Hardy studied at the University of Massachusetts Amherst from 1993 to 1997. His education provided a foundation for his career in the pharmaceutical industry, equipping him with essential skills and knowledge relevant to his roles in pharmacovigilance and analytics.
Career Progression in Pharmacovigilance
Christopher Hardy's career in pharmacovigilance began at Sanofi Genzyme, where he worked as a Clinical Database Programmer from 2003 to 2010. He then transitioned to the role of Reporting Manager at the same company until 2012. His career continued to advance as he took on positions at Vertex Pharmaceuticals and Aimmune Therapeutics, ultimately leading to his current role at Day One Biopharmaceuticals.